Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura
- PMID: 560229
Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura
Abstract
Two patients with thrombotic thrombocytopenic purpura (TTP) have recovered completely after intensive plasmapheresis. The mechanisms responsible for the improvement in these instances are most likely related to the removal of an inciting or damaging agent. The possibility that this agent may be an immune complex is discussed. Plasmapheresis appears to be useful therapy for some patients with this syndrome.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
